Results 111 to 120 of about 43,151 (205)
ABSTRACT Background and Aims Coronavirus disease 2019 (COVID‐19) affects multiple organs, including the liver. Although pediatric patients generally experience milder disease, liver involvement has been increasingly reported, and its impact on outcomes remains unclear.
Shahnaz Armin +10 more
wiley +1 more source
A Case of Severe Fever with Thrombocytopenia Syndrome
Kei, Araki +8 more
openaire +3 more sources
Assessing the Origin of the COVID19 Pandemic Is Still Important
ABSTRACT The COVID19 pandemic, caused by the betacoronavirus SARS‐CoV‐2, now ranks among the world's deadliest plagues, and certainly one of the most significant public health crises in the last 100 years. Despite more than 6 years of investigating the pandemic, it has been difficult to assess the origin of the disease in the City of Wuhan, China.
Jason D. Bannan
wiley +1 more source
Architecture of severe fever with thrombocytopenia syndrome virus
Zixian Sun +8 more
openaire +2 more sources
Lysine l‐Lactylation: Bridging Metabolism, Chromatin and Disease
Enzymatic regulation of KL‐la. The enzymatic regulation of KL‐la involves two distinct pathways for L‐lactate accumulation: intracellular production through glycolysis‐derived pyruvate conversion by lactate dehydrogenase (LDH) or direct cellular uptake via monocarboxylate transporters (MCTs). These L‐lactate pools fuel two distinct lactylation pathways—
Anoosha Malik +10 more
wiley +1 more source
Prediction of Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome
This study aimed to understand the clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) and identify the risk factors for prognosis. In this retrospective study, we collected epidemiological, demographic, clinical, and laboratory data from 101 patients with SFTS.
Zhang, Yi +5 more
openaire +2 more sources
ABSTRACT Hepatotoxicity is a common and significant adverse effect associated with adeno‐associated virus (AAV) gene therapy; however, the underlying mechanisms remain unknown. In this study, we demonstrated innate immune activation in two patients with spinal muscular atrophy shortly after receiving AAV9 gene therapy with onasemnogene abeparvovec ...
Aiko Sakai +7 more
wiley +1 more source
Abstract Background Platelet transfusion refractoriness (PTR) is a major challenge in transfusion medicine and may result from both immune and non‐immune mechanisms. Although alloantibodies are well‐established contributors, Fc‐independent pathways such as platelet desialylation have emerged as alternative mechanisms of clearance.
Karen Ziza +11 more
wiley +1 more source
Acta Paediatrica, Volume 115, Issue 8, Page 1801-1803, August 2026.
Antonio Corsello +4 more
wiley +1 more source
Ecological signature on the epidemiological dynamics of severe fever with thrombocytopenia syndrome. [PDF]
Lou Z +8 more
europepmc +1 more source

